News Coverage 11.01.16 Share on Twitter Share on Facebook Share on LinkedIn The Iconoclast JIM ALLISON HAS ALWAYS GONE HIS OWN WAY—AS A SMALL-TOWN-TEXAS KID WHO PREFERRED BOOKS TO FOOTBALL, AND AS A YOUNG SCIENTIST WHO BELIEVED THE IMMUNE SYSTEM COULD TREAT TUMORS WHEN FEW OTHERS DID. AND THAT IRREVERENCE LED HIM TO FIND A POTENTIAL CURE FOR CANCER. In May 2001 a middle-aged woman named Sharon visited her oncologist for what she thought could be her final appointment. Two months earlier, Sharon had been diagnosed with metastatic melanoma, and her condition was already well beyond dire. Her liver was riddled with metastases, a massive tumor was slowly collapsing her left lung, and fluid was pooling in the pleural cavity of her chest. Doctors didn’t expect her to live more than a few weeks. Related Announcement PICI Hosts 2024 Spring Scientific Retreat Press Release BostonGene and the Parker Institute for Cancer Immunotherapy Collaborate to Generate Comprehensive Longitudinal Multi-Omic Data for Predicting Immunotherapy Outcomes Announcement, From Bench to Fireside Episode Nine: Katie Campbell, PhD
Press Release BostonGene and the Parker Institute for Cancer Immunotherapy Collaborate to Generate Comprehensive Longitudinal Multi-Omic Data for Predicting Immunotherapy Outcomes